H19 and breast cancer: Recently, increasing evidence has indicated that H19 expression is significantly associated with abnormal Wnt/β-catenin signaling pathways in various types of human cancers, such as pancreatic cancer, CRC, glioma, breast cancer, and bladder cancer.